Terapéutica génica y farmacogenómica
TerGenOMIC
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (8)
2022
-
Natural killer cell receptors and ligand variants modulate response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia
HLA, Vol. 99, Núm. 2, pp. 93-104
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
High-throughput genotyping of HLA-G, HLA-F, MICA, and MICB and analysis of frequency distributions in healthy blood donors from Catalonia
HLA, Vol. 97, Núm. 5, pp. 420-427
-
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia
Leukemia and Lymphoma, Vol. 62, Núm. 3, pp. 659-668
2020
-
Distribution of human killer cell immunoglobulin-like receptors and ligands among blood donors of Catalonia
HLA, Vol. 95, Núm. 3, pp. 179-188
2019
2018
-
Design and Validation of a Multiplex KIR and HLA Class I Genotyping Method Using Next Generation Sequencing
Frontiers in Immunology, Vol. 9